These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7092438)

  • 41. [Rare clinical forms of multiple myeloma].
    Golenkov AK
    Ter Arkh; 1994; 66(12):90-2. PubMed ID: 7900059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
    Du W; Hattori Y; Hashiguchi A; Kondoh K; Hozumi N; Ikeda Y; Sakamoto M; Hata J; Yamada T
    Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Periodic fever as the only presenting symptom of multiple myeloma in a young man.
    Trakatelli C; Kintiraki E; Koratzis J; Gamvrili L; Kotsis V; Sion M
    J Biol Regul Homeost Agents; 2008; 22(4):263-5. PubMed ID: 19036229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early response to therapy and survival in multiple myeloma.
    Schaar CG; Kluin-Nelemans JC; le Cessie S; Franck PF; te Marvelde MC; Wijermans PW
    Br J Haematol; 2004 Apr; 125(2):162-6. PubMed ID: 15059138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.
    Sordillo EM; Pearse RN
    Cancer; 2003 Feb; 97(3 Suppl):802-12. PubMed ID: 12548579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anion gap among patients of multiple myeloma and normal individuals.
    Mansoor S; Siddiqui I; Adil S; Nabi Kakepoto G; Fatmi Z; Ghani F
    Clin Biochem; 2007 Feb; 40(3-4):226-9. PubMed ID: 17156769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acid gel reaction--a rapid and inexpensive laboratory test for the diagnosis of multiple myeloma, and its correlation with immunoglobulins.
    Kate SL; Mutalik GS; Bapat JP; Baxi AJ
    J Assoc Physicians India; 1973 Aug; 21(8):693-6. PubMed ID: 4793015
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria.
    Sirohi B; Powles R; Kulkarni S; Rudin C; Saso R; Lal R; Singhal S; Mehta J; Horton C; Treleaven J
    Bone Marrow Transplant; 2001 Jul; 28(1):29-37. PubMed ID: 11498741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [On the diagnosis of multiple myeloma an analysis of 2,547 domestic cases].
    Li S; Li H; Zhao X
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):43-6. PubMed ID: 7656787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aberrant glycosylation of Igg heavy chain in multiple myeloma.
    Aurer I; Lauc G; Dumić J; Rendić D; Matisić D; Milos M; Heffer-Lauc M; Flogel M; Labar B
    Coll Antropol; 2007 Mar; 31(1):247-51. PubMed ID: 17598409
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A simple screening procedure for detection of infraclinical cases of multiple myeloma.
    Pandey J; Kothari SY; Lata K; Talib VH; Shrivastava RK
    Indian J Pathol Microbiol; 1993 Oct; 36(4):453-7. PubMed ID: 8157315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Auer rod-like inclusions in myeloma cells in a patient with IgG multiple myeloma.
    Das S; Kakkar N; Ahuja B; Lal M
    Indian J Pathol Microbiol; 2006 Oct; 49(4):561-3. PubMed ID: 17183855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diagnostic and prognostic significance of blood-serum ceruloplasmin, acetylcholinesterase and total proteolytic activity in patients with multiple myeloma].
    Bessmel'tsev SS; Rybakova LP; Gritskevich NL; Golota GZ; Blinov MN; Abdulkadyrov KM
    Vopr Onkol; 1999; 45(4):398-404. PubMed ID: 10532099
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IgD-kappa myeloma: an unusual case.
    Tharp AM; Woodruff RD; Shihabi ZK
    Ann Clin Lab Sci; 2003; 33(1):97-100. PubMed ID: 12661904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantification of daratumumab in the serum protein electrophoresis.
    Jialal I; Pahwa R
    Clin Chem Lab Med; 2017 Feb; 55(2):e27-e28. PubMed ID: 27718485
    [No Abstract]   [Full Text] [Related]  

  • 56. Differential binding affinity of immobilized Concanavalin A-Sepharose 4B for normal and myelomatous immunoglobulins.
    Ray PK; Raychaudhuri S
    Biomed Pharmacother; 1982; 36(4):206-10. PubMed ID: 7165790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple myeloma uncovered by investigating a negative serum iron level.
    Wu LC; Chuang SS; Lin CN; Su CC; Lin MP
    J Clin Pathol; 2007 Jan; 60(1):110. PubMed ID: 17213363
    [No Abstract]   [Full Text] [Related]  

  • 58. PAS staining and immunoglobulin classes in myeloma.
    Brumana N; Andreoni MA; Marnini P; Parravicini U; Salmini G
    Haematologica; 1982 Apr; 67(2):319-20. PubMed ID: 6807779
    [No Abstract]   [Full Text] [Related]  

  • 59. Accidental Diagnosis of Multiple Myeloma in a 44-Year-Old White Woman due to Erroneous Results via Chemical Analyzers.
    Bashiti O
    Lab Med; 2016 Feb; 47(1):e5-e11. PubMed ID: 26715610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Sudden deafness and modification of plasma proteins].
    Charachon R; Serero C; Juniel-Lavillauroy C; Roux O
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Sep; 23(7):615-6, 619-20. PubMed ID: 4280424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.